Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Annual Report · 10-K

BioForce Nanosciences Holdings, Inc.

BFNHOTCEQUITYCurrent

Annual Report

Filed Mar 28, 2023Accepted Mar 28, 2023, 12:40 PM EDTCIK 1310488Accession 0001091818-23-000044
Share

Company context

Current securities

Recent company filings

  1. SCHEDULE 13D filingSep 4, 2026
  2. Unregistered Sales of Equity SecuritiesSep 4, 2026
  3. 4 filingSep 2, 2026
  4. Regulation FD DisclosureAug 18, 2026
  5. Other EventsAug 14, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗